Capital World Investors 13D and 13G filings for Alnylam Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-09 6:14 pm Sale |
2024-02-07 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 16,398,889 13.100% |
-195,069 (-1.18%) |
Filing |
| 2023-02-13 2:49 pm Purchase |
2023-02-14 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 16,593,958 13.500% |
3,777,181 (+29.47%) |
Filing |
| 2022-09-09 12:30 pm Purchase |
2022-09-09 | 13G | Alnylam Pharmaceuticals, Inc. ALNY |
Capital World Investors | 12,816,777 10.700% |
12,816,777 (New Position) |
Filing |